45
Views
27
CrossRef citations to date
0
Altmetric
Original Articles

Antibodies to Molds and Satratoxin in Individuals Exposed in Water-Damaged Buildings

, , , , &
Pages 421-432 | Accepted 30 Oct 2003, Published online: 21 Jun 2017

References

  • Gravesen S, Nielsen PA, Iversen R, et al. Microfungal contamination of damp buildings—examples of constructions and risk materials. Environ Health Perspect 1999; 107(suppl 3):505–08.
  • Croft WA, Jarvis BB, Yatawara CS. Airborne outbreak of trichothecene toxicosis. Atmos Environ 1986; 20:549–52.
  • Peltola J, Andersson MA, Haahtela T, et al. Toxic-metabolite–producing bacteria and fungus in an indoor environment. Appl Environ Microbiol 2001; 67:3269–74.
  • Shelton BF, Kirkland KH, Flanders WE, et al. Profiles of airborne fungi in buildings and outdoor environments in the United States. Appl Environ Microbiol 2002; 68:1743–53.
  • Johanning E, Biagini R, Hull DL, et al. Health and immunology study following exposure to toxigenic fungi (Stachybotrys chartarum) in a water-damaged office environment. Int Arch Occup Environ Health 1996; 68:207–18.
  • Andersson MA, Nikulin M, Kooljalg U, et al. Bacteria, molds, and toxins in water-damaged building materials. Appl Environ Microbiol 1997; 63:387–93.
  • Nielsen KF, Gravesen S, Nielsen PA. Production of mycotoxins on artificially and naturally infested building materials. Mycopathologia 1999; 145:43–56.
  • Claeson AS, Levin H, Blomquist G, et al. Volatile metabolites from microorganisms grown on humid building materials and synthetic media. J Environ Monit 2002; 4:667–72.
  • Tuomi T, Reijut K, Johnsson T, et al. Mycotoxins in crude building materials from water-damaged buildings. Appl Environ Microbiol 2000; 66:1899–1904.
  • Nieminen SM, Karki R, Auriola S, et al. Isolation and indentification of Aspergillus fumigatus mycotoxins on growth medium and some building materials. Microbiology 2002; 68:4871–75.
  • Jarvis BB. Chemistry and toxicology of molds isolated from water-damaged buildings. In: DeVries JW, Trucksess MW, Jackson LS (Eds). Mycotoxins and Food Safety. Kluwer Academic/Plenum Publishers, 2002; pp 43–52.
  • Burge HA. Bioaerosols: Prevalence and health effects in the indoor environment. J Allergy Clin Immunol 1990; 86:687–704.
  • Richard JL, Plattner RD, May J, et al. The occurrence of ochratoxin A in dust collected from a problem household. Mycopathologia 1999; 146:99–103.
  • Skaug MA, Eduard W, Stormer FD. Ochratoxin A in airborne dust and fungal conidia. Mycopathologia 2000; 151:93–95.
  • Smoragiewicz W, Cossete B, Boutrard A, et al. Trichothecene mycotoxins in the dust of ventilation systems in office buildings. Int Arch Occup Environ Health 1993; 65:113–17.
  • Tuomi T, Saarinene L, Reijula K. Detection of polar and macrocyclic trichothecene mycotoxins from indoor environments. Analyst 1998; 123:1835–41.
  • Jarvis BB, Yatawara CS. Airborne outbreak of trichothecene toxicosis. Atmos Environ 1986; 29:549–52.
  • Johanning E, Gareis M, Nielsen K, et al. Airborne mycotoxins sampling and screening analysis. Proceedings of the 9th International Conference on Indoor Air Quality and Climate (Indoor Air 2002), Monterey, California, June 30–July 5, 2002. Santa Cruz, CA: Indoor Air 2002 Conference Secretariat.
  • Flannigan B, McCabe EM, McGarry F. Allergenic and toxigenic microorganisms in houses. J Appl Bact Sym 1991; 70(suppl):61–73.
  • Jaakkola M, Nordman H, Pilpari R, et al. Indoor dampness and molds and development of adult-onset asthma: A population-based incident case-control study. Environ Health Perspect 2002; 110:543–47.
  • Kurup V, Shen HD, Banerjee B. Respiratory fungal allergy. Microbes Infect 2000; 2:1101–10.
  • Zureik M, Neukirch C, Leynaert B, et al. Sensitization to airborne moulds and severity of asthma: Cross sectional study from European Community respiratory health survey. Br Med J 2002; 325(7361):411–14.
  • Hodgson MJ, Morey P, Leung WY, et al. Building-associated pulmonary disease from exposure to Stachybotrys chartarum and Aspergillus versicolor. J Occup Environ Med 1998; 40(3):241–49.
  • Patel AM, Ryu JH, Reed CE. Hypersensitivity pneumonitis: Current concepts and future questions. J Allergy Clin Immunol 2001; 108:661–70.
  • Fan LL. Hypersensitivity pneumonitis in children. Curr Opin Pediatr 2002; 14:323–26.
  • Lander F, Meyer HW, Norm S. Serum IgE specific to moulds, measured by basophil histamine release, is associated with building-related symptoms in damp buildings. Inflamm Res 2001; 50:227–31.
  • Potter PC, Juritz J, Little F, et al. Clustering of fungal allergen-specific IgE antibody responses in allergic subjects. Ann Allergy 1991; 66:149–53.
  • Ezeamuzie CI, Al-Ali S, Kahn M, et al. IgE-mediated sensitization to mould allergens among patients with allergic respiratory diseases in a desert environment. Int Arch Allergy Immunol 2000; 121:300–07.
  • Karlsson-Borga A, Jonsson P, Rolfsen W. Specific IgE antibody to 16 widespread mold genera in patients with suspected mold allergy. Ann Allergy 1989; 63:521–26.
  • Raunio P, Pasanen AL, Husman T, et al. Exposure to Stachybotrys chartarum induces immunoglobulin A antibody response in man. In: Johanning E (Ed). Bioaerosols, Fungi and Mycotoxins: Health Effects, Assessment, Prevention and Control. Albany, NY: Eastern New York Occupational and Environmental Health Center, 1999; pp 174–78.
  • Knutsen AP, Mueller KR, Hutcheson PS, et al. Serum anti-Aspergillus fumigatus antibody immunoblot and ELISA in cystic fibrosis with allergic bronchopulmonary aspergillosis. J Clin Immunol 1994; 93:926–31.
  • Ojanen T, Tukiainen H, Mantyjarvi RA. Class-specific antibodies during follow-up of patients with farmer's lung. Eur Respir J 1990; 3:257–60.
  • Apter AJ, Greenberger PA, Liotta JL, et al. Fluctuation of serum IgA and its subclasses in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1989; 84:367–72.
  • Erkinjuntti-Pekkanen R, Reiman M, Kokkarinen JI, et al. IgG antibodies, chronic bronchitis, and pulmonary function values in farmer's lung patients and matched controls. Allergy 1999; 54:1181–87.
  • Marr KA. Candida species: Emergence of drug-resistant pathogens. Program and Abstracts of the 38th Annual Meeting of the Infectious Diseases Society of America (IDSA). September 2000, New Orleans, Louisiana. Alexandria, VA: IDSA; Abstract S65.
  • Marr KA, Seidel K, White TC, et al. Candidemia in allogeneic blood and marrow transplant recipients: Evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis 2000; 181:309–16.
  • Wrobel CJ, Chappell ET, Taylor W. Clinical presentation, radiological findings, and treatment results of coccidioidomycosis involving the spine: Report on 23 cases. J Neurosurg 2001; 95(suppl 1):33–39.
  • Grossi P, Farina C, Fiocchi R, et al. Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: A multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. Transplantation 2000; 70:112–16.
  • Anaissie EJ, Stratton SL, Dignani MC, et al. Pathogenic Aspergillus species recovered from a hospital water system: 3-year prospective study. Clin Infect Dis 2002; 34:780–89.
  • Fraser RS. Pulmonary aspergilliosis: Pathologic and pathogenetic features. Pathol Annu 1993; 28:231–77.
  • Ferguson BJ. Mucormycosis of the nose and paranasal sinuses. Otolaryngol Clin North Am 2000; 33:349–65.
  • Eucker J, Sezer O, Graf B, et al. Mucormycoses. Mycoses 2001; 44:253–60.
  • Sumi Y, Nagura H, Takeuchi M, et al. Granulomatous lesions in the lung induced by inhalation of mold spores. Virchows Arch 1994; 424:661–68.
  • Kamei K. Animal models of zygomycosis—Absidia, Rhizopus, Rhizomucor, and Cunninghamella. Mycopathologia 2001; 152:5–13.
  • Woods JP, Heinecke EL, Luecke JW, et al. Pathogenesis of Histoplasma capsulatum. Semin Respir Infect 2001; 16:91–101.
  • Bhargava D, Bhusnurmath B, Sundaran KR, et al. Tonsillar actinomycosis: A clinicopathology study. Acta Trop 2001; 80:163–68.
  • Feldman BS, Snuder LS. Primary pulmonary coccidioidomycosis. Semin Respir Infect 2001; 16:231–37.
  • Liratsopulos G, Ellis M, Nerringer R, et al. Invasive infection due to Penicillium species other than P. marneffei. J Infect 2002; 45:184.
  • Dosa E, Coczi I, Mojzes EG, et al. Identification and incidence of fungal strains in chronic rhinosinusitis patients. Acta Microbiol Immunol Hung 2002; 49:337–46.
  • Taylor MJ, Pnikaue JU, Sherris DA, et al. Detection of fungal organisms in eosinophilic mucin using a fluorescein-labeled chitin-specific binding protein. Otolaryngol Head Neck Surg 2002; 127:377–83.
  • Etzel RA, Montana E, Sorenson WB, et al. Pulmonary hemorrhage in infants associated with exposure to Stachybotrys atra and other fungi. Arch Pediatr Adolesc Med 1998; 152:757–62.
  • Dearborn DG, Yike I, Sorenson WG, et al. An overview of the investigations into pulmonary hemorrhage among infants in Cleveland, Ohio. Environ Health Perspect 1999; 107(suppl):495–99.
  • Montana E, Etzel RA, Allan T, et al. Environmental risk factors associated with pediatric idiopathic pulmonary hemorrhage and hemosiderosis in a Cleveland community. Pediatrics 1997; 99:E5.
  • Montana E, Etzel RA, Dearborn DG, et al. Acute pulmonary hemorrhage in infancy associated with Stachybotrys atra, Cleveland, Ohio. Am J Epidemiol 1995; 141:583.
  • Elidemer O, Colasurdo GN, Rossman SN, et al. Isolation of Stachybotrys from the lung of a child with pulmonary hemosiderosis. Pediatrics 1999; 104:964–66.
  • Vesper SJ, Dearborn DG, Elidemer O, et al. Quantification of siderophore and hemolysin from Stachybotrys chartarum strains, including a strain isolated from the lung of a child with pulmonary hemorrhage and hemosiderosis. Appl Environ Microbiol 2000; 66:2678–81.
  • Vesper SJ, Magnusson H, Dearborn DG, et al. Initial characterization of the hemolysin stachylysin from Stachybotrys chartarum. Infect Immun 2001; 69:912–16.
  • Vesper SJ, Vesper MJ. Stachylysin may be a cause of hemorrhaging in humans exposed to Stachybotrys chartarum. Infect Immun 2002; 70:2065–69.
  • Vesper S, Dearborn DG, Yike I, et al. Evaluation of Stachybotrys chartarum in the house of an infant with pulmonary hemorrhage: Quantitative assessment before, during, and after remediation. J Urban Health 2000; 77:68–85.
  • Jarvis BB, Sorenson WG, Hintikka EL, et al. Study of toxin production by isolates of Stachybotrys chartarum and Memnoniella echinata isolated during a study of pulmonary hemosiderosis in infants. Appl Environ Microbiol 1998; 64:3620–25.
  • Kordula T, Banbula A, Macomson J, et al. Isolation and properties of Stachyrase A, a chymotrypsin-like serine proteinase from Stachybotrys chartarum. Infect Immun 2002; 70:419–21.
  • Rand TG, Mahoney M, White K, et al. Microanatomical changes in alveolar type II cells in juvenile mice intrathecally exposed to Stachybotrys chartarum spores and toxin. Toxicol Sci 2002; 65:239–45.
  • Mason CD, Rand TG, Oulton M, et al. Effects of Stachybotrys chartarum (atra) conidia and isolated toxin on lung surfactant production and homeostasis. Nat Toxins 1998; 6:27–33.
  • McCrae KC, Rand T, Shaw RA, et al. Analysis of pulmonary surfactants by Fourier-transform infrared spectroscopy following exposure to Stachybotrys chartarum (atra) spores. Chem Phys Lipids 2001; 110:1–10.
  • Mason CD, Rand TG, Oulton M, et al. Effects of Stachybotrys chartarum on surfactant convertase activity in juvenile mice. Toxicol Appl Pharmacol 2001; 172:21–28.
  • Kudo Y, Ootani T, Kumangai T, et al. A novel oxidized low-density lipoprotein-binding protein, Asp-hemolysin recognizes lysophosphatidylcholine. Biol Pharm Bull 2002; 25:787–90.
  • Ebina K, Ichinowatari S, Yokota K. Studies on toxin Aspergillus fumigatus. XXII. Fashion of binding Asp-hemolysin to human erythrocytes and Asp-hemolysin-binding proteins of erythrocyte membranes. Microbiol Immunol 1985; 29:91–101.
  • Monod M, Capoccia S, Lechene B, et al. Secreted proteases from pathogenic fungi. Int J Med Microbiol 2002; 292:405–19.
  • Jarvis BB, Salemme J, Morais A. Stachybotrys toxins. Nat Toxins 1995; 3:10–16.
  • Jarvis BB, Zhou Y, Wang S. Toxigenic molds in water-damaged buildings: Dechlorogriseofulvins from Memnoniella echinata. J Nat Prod 1996; 59:553–54.
  • Gareis M. Cytotoxicity testing of samples originating from problem buildings. In: Johanning E, Yang CS (Eds). Proceedings of the International Conference: Fungi and Bacteria in Indoor Air Environments: Health Effects, Detection and Remediation, Saratoga Springs, New York, October 1994. Albany, NY: Eastern New York Occupational and Environmental Health Center, 1995; pp 139–44.
  • Jakab GJ, Hmieleski RR, Hemenway DR, et al. Respiratory aflatoxicosis: Suppression of pulmonary and systemic host defenses in rats and mice. Toxicol Appl Pharmacol 1994; 125:198–205.
  • Nagata T, Suzuki H, Ishigami N, et al. Development of apoptosis and changes in lymphocyte subsets in thymus, mesenteric lymph nodes and Peyer's patches of mice orally inoculated with T-2 toxin. Exp Toxicol Pathol 2001; 52:309–15.
  • Jones C, Ciacci-Zanella JR, Zhang V, et al. Analysis of fumonisin B1-induced apoptosis. Environ Health Perspect 2001; 109(suppl 2):315–20.
  • Poapolathep A, Ohtsuka R, Kiatipattanasakul W, et al. Nivalenol-induced apoptosis of thymus, spleen, and Peyer's patches of mice. Exp Toxicol Pathol 2002; 53:441–46.
  • Desai K, Sullards MC, Allegood J, et al. Fumonisins and fumonisin analogs as inhibitors of ceramide synthase and inducers of apoptosis. Biochim Biophys Acta 2002; 1585:188–92.
  • Pace JG. Effect of T-2 mycotoxin on rat liver mitochondria electron transport system. Toxicon 1983; 21:675–80.
  • Pace JG. T-2 mycotoxin inhibits mitochondrial protein synthesis. Toxicon 1988; 26:77–85.
  • Pfohl-Leszkowicz A, Petkova-Bocharova T, Chernozemsky IN, et al. Balkan endemic nephropathy and associated urinary tract tumors: A review on aetiolgical causes and the potential role of mycotoxins. Food Addit Contam 2002; 19:282–302.
  • Pfohl-Leszkowicz A, Grosse Y, Kane A, et al. Differential DNA adduct formation and disappearance in three mouse tissues after treatment with mycotoxin ochratoxin A. Mutat Res 1993; 289:265–73.
  • Schwartz GG. Does ochratoxin A cause testicular cancer? Cancer Causes Control 2002; 13:91–100.
  • Petkova-Bochatrova T, Stoichev II, Chernozemsky IN, et al. Formation of DNA adducts in tissue of mouse progeny through transplacental contamination and/or lactation after administration of single does of ochratoxin A to the pregnant mother. Environ Mol Mutagen 1998; 32:155–62.
  • Hochler D, Marquardt RR, McIntosh AR, et al. Induction of free radicals in hepatocytes, mitochondria and microsomes of rats by ochratoxin A and its analogs. Biochim Biophys Acta 1997; 1357:225–33.
  • Sajan MP, Satav JG, Battacharya RK. Effect of aflatoxin B1 in vitro on rat liver mitochondrial respiratory functions. Indian J Exp Biol 1997; 35:1187–90.
  • Hisch LL, Hisch TT. Detection of aflatoxin B1-DNA adducts in human placenta and cord blood. Cancer Res 1993; 53:1278–80.
  • Miranjan BF, Bhat NK, Avadhani NG. Preferential attack of mitochondrial DNA by aflatoxin B1 during hepatocarcinogenesis. Science 1982; 214(4528):73–75.
  • Dominguez-Malagon H, Gaytan-Graham S. Hepatocellular carcinoma: An update. Ultrastruct Pathol 2001; 25:497–516.
  • Croft WA, Jastromski BM, Croft AL, et al. Clinical confirmation of trichothecene mycotoxicosis in patient urine. J Environ Biol 2002; 23:301–20.
  • Kilburn KH. Inhalation of moulds and mycotoxins. Eur J Oncol 2002; 7:197–202.
  • Anyanwu EC, Campbell AW, Vojdani A. Neurophysiological effects of chronic indoor environmental mold exposure on children. Scientific World Journal 2003; 3:281–90.
  • Mahmoudi M, Gershwin ME. Sick building syndrome. III. Stachybotrys chartarum. J Asthma 2000; 37:191–98.
  • Walinder R, Wieslandr G, Norback D, et al. Nasal lavage biomarkers: Effects of water damage and microbial growth in an office building. Arch Environ Health 2001; 56:30–36.
  • Gray MR, Thrasher JD, Crago R, et al. Mixed mold mycotoxicosis: Immunological changes in humans following exposure in water-damaged buildings. Arch Environ Health 2003; 58(7):410–20.
  • Crago R, Gray MR, Nelson LA, et al. On the neuropsychological and electrocortical impact of mixed mold exposure. Arch Environ Health 2003; 58(8). Forthcoming.
  • Campbell AW, Thrasher JD, Madison RA, et al. Autoantibodies and neurophysiologic abnormalities in patients exposed to molds in water-damaged buildings. Arch Environ Health 2003; 58(8). Forthcoming.
  • Achatz G, Oberkofler H, Lechenauer E, et al. Molecular cloning of major and minor allergens of Alternaria alternata and Cladosporium herbarum. Mol Immunol 1995; 32:213–27.
  • Paris S, Fitting E, Ramirez E, et al. Comparison of different extraction methods of Alternaria allergens. J Allergy Clin Immunol 1990; 85:941–48.
  • Portnoy J, Pacheco F, Ballam Y, et al. The effect of time and extraction buffers on residual protein and allergen content of extracts derived from four strains of Alternaria. J Allergy Clin Immunol 1993; 91:930–38.
  • Raunio P, Karkkainen M, Virtanen T, et al. Preliminary description of antigenic components of Stachybotrys chartarum. Environ Res 2001; 85:246–55.
  • Vojdani A, Campbell A, Kashanian A, et al. Antibodies against molds and mycotoxins following exposure to toxigenic fungi in a water-damaged building. Arch Environ Health 2003. 58(6):324–36.
  • Brostoff J. Immunological mechanisms. In: Brostoff J, Challacombe SJ (Eds). Food Allergy and Intolerance. Eastborne, England: W.B. Saunders, 1976; pp 433–55.
  • Saxon A, Diaz-Sanchez D, Zhang K. The allergic response in host defense. In: Rich RR, Fleisher TA, Schwartz BD, et al (Eds). Clinical Immunology. St. Louis, MO: Mosby, 1995; pp 847–69.
  • Gent JF, Ren P, Belanger K, et al. Levels of household mold associated with respiratory symptoms in the first year of life in a cohort at risk for asthma. Environ Health Perspect 2002; 110:A781–86.
  • Gell PGH, Coombs RRA. Clinical Aspects of Immunology. Oxford, U.K.: Blackwell, 1963.
  • Johanning E, Landsbergis P, Gareis M, et al. Clinical experience and results of a sentinel health investigation related to indoor fungal exposure. Environ Health Perspect 1999; 107(suppl 3):189–94.
  • Hyvarinen A, Reiman M, Meklin T, et al. Fungal exposure and IgG-levels with and without mold problems. In: Johanning E (Ed). Bioaerosols, Fungi and Mycotoxins: Health Effects, Assessment, Prevention and Control. Albany, NY: Eastern New York Occupational and Environmental Health Center, 1999; 99:166–68.
  • Autrup H, Sermet T, Wakhisi J. Evidence for human antibodies that recognize aflatoxin epitope in groups with high and low exposure to aflatoxins. Arch Environ Health 1990; 45:31–34.
  • Wild CP, Jiang YX, Sabbioni G, et al. Evaluation of methods for quantitation of aflatoxin-albumin adducts and their application to human exposure assessment. Cancer Res 1990; 50:245–51.
  • Gathumbi JK, Usleber E, Martlbauer E. Production of ultra-sensitive antibodies against aflatoxin B1. Lett Appl Microbiol 2001; 32:349–51.
  • McElroy JL, Weiss CM. The production of polyclonal antibodies against the mycotoxin derivative patulin hemiglutarate. Can J Microbiol 1993; 39:861–63.
  • Solti L, Salamon F, Barna-Vetro I, et al. Ochratoxin A content of human sera determined by a sensitive ELISA. J Anal Toxicol 1997; 21:44–48.
  • Breitholtz EA, Hult K. Enzyme-linked immunosorbent assay for analysis of ochratoxin A in human plasma samples using antibodies raised against ochratoxin-protein conjugate. IARC Sci Publ 1991; 115:89–92.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.